Gheuens Sarah

CIK 00018811902 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001881190

Recent Transactions

50 trades

Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30+6,000→ 67,727 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30$27.09/sh−2,932→ 64,795 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-12-30−6,000→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-11-11$25.01/sh+2,454→ 64,181 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-11-11$43.78/sh−2,454→ 61,727 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-11-11−2,454→ 26,130 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-30$43.81/sh−200→ 61,727 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-10-30−200→ 28,584 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-30$25.01/sh+200→ 61,927 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-10-27−3,302→ 28,784 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-27$43.92/sh−3,302→ 61,727 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-27$25.01/sh+3,302→ 65,029 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-09$25.01/sh+11,914→ 73,185 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-07-09−11,914→ 32,086 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-09$38.76/sh−847→ 61,271 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-09$37.93/sh−11,067→ 62,118 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2025-07-01+21,000→ 21,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-01+8,374→ 65,362 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-07-01−8,374→ 8,375 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-01$34.17/sh−4,091→ 61,271 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24$33.54/sh−2,909→ 56,988 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24+6,000→ 59,897 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-06-24−6,000→ 6,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,681→ 53,897 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,187→ 49,911 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,137→ 47,098 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−5,667→ 11,333 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+5,667→ 55,578 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01+12,000→ 12,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−4,000→ 4,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+3,833→ 48,235 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+4,000→ 51,098 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-03-01+43,500→ 43,500 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−3,833→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-07-01+8,375→ 47,441 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-07-01$43.85/sh−3,705→ 43,736 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-07-01−8,375→ 16,749 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2024-06-26+21,000→ 21,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-05$32.57/sh−1,293→ 36,415 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-05$32.57/sh−1,349→ 39,066 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01−3,834→ 3,833 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-03-01+60,000→ 60,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01+17,000→ 17,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-01+4,000→ 40,415 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-01+3,834→ 37,708 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01−4,000→ 8,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-14$25.14/sh−642→ 33,431 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-02-12−2,162→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-12+2,162→ 34,073 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-24$21.64/sh−1,708→ 31,911 total

Companies

Recent Filings

Address

88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov